Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Cortes

Showing results (221-230 of 584) with videos related to

Pageof 59
Sort By:
Leukemia & Lymphoma|May 22, 2014
The effect of decitabine dose modification and myelosuppression on response and survival in patients with myelodysplastic syndromesElias Jabbour, Guillermo Garcia-Manero, A Megan Cornelison, et al.
JAAD International|October 14, 2024
The intersection of melanoma survival and social determinants of health in the United States: A systematic reviewMcKenzie E Maloney, Caleb Bacak, Kellen Tjioe, et al.
The Annals of Pharmacotherapy|August 19, 2003
Intravenous corticosteroids to reduce gemtuzumab ozogamicin infusion reactionsFrancis J Giles, Jorge E Cortes, Terri A Halliburton, et al.
Cancer|June 15, 1994
All-trans retinoic acid followed by chemotherapy for salvage of refractory or relapsed acute promyelocytic leukemiaJ E Cortes, H Kantarjian, S O'Brien, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 15, 2013
CD30 expression in high-risk acute myeloid leukemia and myelodysplastic syndromesWenli Zheng, L Jeffrey Medeiros, Ying Hu, et al.
Journal of Clinical Pathology|May 25, 2013
Double-hit of FLT3 gene in a fatal case of acute myemonocytic leukaemiaGary Lu, Roger A Schulz, Carlos E Bueso-Ramos, et al.
The European Respiratory Journal|January 7, 2000
Inhaled NO and almitrine bismesylate in patients with acute respiratory distress syndrome: effect of noradrenalinL Papazian, F Bregeon, F Gaillat, et al.
The New England Journal of Medicine|April 13, 1989
HIV-1, HIV-2, and HTLV-I infection in high-risk groups in BrazilE Cortes, R Detels, D Aboulafia, et al.
European Journal of Haematology|February 27, 2021
Long-term cardiac, vascular, hypertension, and effusion safety of bosutinib in patients with Philadelphia chromosome-positive leukemia resistant or intolerant to prior therapyJorge E Cortes, Hagop M Kantarjian, Michael J Mauro, et al.
Leukemia|May 22, 2026
From fatal disease to functional cure: 25 years of tyrosine kinase inhibition in chronic myeloid leukemiaAndreas Hochhaus, Moshe Talpaz, Giuseppe Saglio, et al.
Pageof 59

Showing results (221-230 of 584) with videos related to

Sort By:
Pageof 59
Leukemia & Lymphoma|May 22, 2014
The effect of decitabine dose modification and myelosuppression on response and survival in patients with myelodysplastic syndromesElias Jabbour, Guillermo Garcia-Manero, A Megan Cornelison, et al.
JAAD International|October 14, 2024
The intersection of melanoma survival and social determinants of health in the United States: A systematic reviewMcKenzie E Maloney, Caleb Bacak, Kellen Tjioe, et al.
The Annals of Pharmacotherapy|August 19, 2003
Intravenous corticosteroids to reduce gemtuzumab ozogamicin infusion reactionsFrancis J Giles, Jorge E Cortes, Terri A Halliburton, et al.
Cancer|June 15, 1994
All-trans retinoic acid followed by chemotherapy for salvage of refractory or relapsed acute promyelocytic leukemiaJ E Cortes, H Kantarjian, S O'Brien, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 15, 2013
CD30 expression in high-risk acute myeloid leukemia and myelodysplastic syndromesWenli Zheng, L Jeffrey Medeiros, Ying Hu, et al.
Journal of Clinical Pathology|May 25, 2013
Double-hit of FLT3 gene in a fatal case of acute myemonocytic leukaemiaGary Lu, Roger A Schulz, Carlos E Bueso-Ramos, et al.
The European Respiratory Journal|January 7, 2000
Inhaled NO and almitrine bismesylate in patients with acute respiratory distress syndrome: effect of noradrenalinL Papazian, F Bregeon, F Gaillat, et al.
The New England Journal of Medicine|April 13, 1989
HIV-1, HIV-2, and HTLV-I infection in high-risk groups in BrazilE Cortes, R Detels, D Aboulafia, et al.
European Journal of Haematology|February 27, 2021
Long-term cardiac, vascular, hypertension, and effusion safety of bosutinib in patients with Philadelphia chromosome-positive leukemia resistant or intolerant to prior therapyJorge E Cortes, Hagop M Kantarjian, Michael J Mauro, et al.
Leukemia|May 22, 2026
From fatal disease to functional cure: 25 years of tyrosine kinase inhibition in chronic myeloid leukemiaAndreas Hochhaus, Moshe Talpaz, Giuseppe Saglio, et al.
Pageof 59